Diuretics | MyMerci
제안하기
0 / 2000

Diuretics

Unit 4 · Topic 16Diuretics
1.Mechanism of Action

Diuretics increase urine output by blocking sodium (and chloride) reabsorption at different parts of the nephron — water follows sodium. The site of action predicts both the strength and the electrolyte effect.

Nephron siteClassTransporter blockedStrengthPotassium effect
Proximal tubuleCarbonic anhydrase inhibitor (acetazolamide)Bicarbonate reabsorptionWeak↓K⁺, metabolic acidosis
Proximal tubule and loop (osmotic)MannitolDraws water into the tubuleStrong water lossVariable
Thick ascending loop of HenleLoop diureticsNa⁺–K⁺–2Cl⁻ cotransporterMost potent (up to about 20–25% of filtered sodium)↓K⁺
Distal convoluted tubuleThiazide and thiazide-likeNa⁺–Cl⁻ cotransporterModerate↓K⁺
Collecting ductPotassium-sparing: aldosterone (mineralocorticoid receptor) antagonists; ENaC blockersAldosterone effect or sodium channelWeak↑K⁺

Why loop and thiazide diuretics lower potassium: more sodium reaches the collecting duct, where it is exchanged for potassium (and hydrogen ions) — so K⁺ is lost and a metabolic alkalosis can develop.

Calcium: loop diuretics increase calcium excretion (used in hypercalcemia); thiazides decrease it (can raise serum calcium; help prevent calcium kidney stones).

2.Indications & Key Drugs
Drug (generic)Key useKey point
Furosemide (prototype loop)Edema from HF, cirrhosis, kidney disease; acute pulmonary edema; hypercalcemia; hyperkalemia (adjunct)IV onset about 5 minutes, oral about 30–60 minutes; oral dose ≈ 2 × IV dose. Give high IV doses slowly — not faster than about 4 mg/min (ototoxicity)
Bumetanide, torsemideSameAbout 40 mg oral furosemide ≈ 1 mg bumetanide ≈ 10–20 mg torsemide
Ethacrynic acidLoop diuretic for true sulfonamide allergyMost ototoxic
Hydrochlorothiazide (prototype thiazide)Hypertension (first-line), mild edema, calcium stone preventionLess effective at low eGFR
Chlorthalidone, indapamide (thiazide-like)HypertensionLonger acting; chlorthalidone has shown BP lowering in advanced CKD
MetolazoneAdded to a loop diuretic for diuretic resistanceProfound diuresis and electrolyte loss — monitor closely
Spironolactone (prototype potassium-sparing)HFrEF, cirrhotic ascites (with furosemide, ratio about 100 mg : 40 mg), resistant hypertension, primary aldosteronism, acne and hirsutismHyperkalemia; gynecomastia, menstrual changes
EplerenoneHFrEF, post-MI HF, hypertensionHyperkalemia; no gynecomastia; contraindicated with strong CYP3A4 inhibitors. For hypertension, also contraindicated with potassium supplements or potassium-sparing diuretics, CrCl < 50 mL/min, or type 2 diabetes with microalbuminuria
Finerenone (nonsteroidal MRA)CKD with type 2 diabetes; HF with LVEF ≥ 40% (FDA 2025)Hyperkalemia; contraindicated with strong CYP3A4 inhibitors
Amiloride, triamtereneWith a thiazide to offset potassium lossHyperkalemia
Mannitol (osmotic)Raised intracranial pressure; acute glaucoma0.25–1 g/kg IV; use an in-line filter (crystals)
Acetazolamide (carbonic anhydrase inhibitor)Glaucoma, prevention of acute mountain sickness, metabolic alkalosisParesthesia, hypokalemia, metabolic acidosis, kidney stones
Tolvaptan (vasopressin antagonist, "aquaretic")Euvolemic or hypervolemic hyponatremiaBoxed warning: start (and restart) only in hospital with close sodium monitoring — too-rapid correction can cause osmotic demyelination; not for ADPKD outside its restricted (REMS) program. Also liver injury (limit duration)

Current guidance

  • Hypertension (2025 AHA/ACC): thiazide-type diuretics are one of four first-line classes; stage 2 hypertension usually starts with two drugs of different classes, preferably in a single pill (e.g., an ACE inhibitor or ARB plus a thiazide).
  • Heart failure: loop diuretics relieve congestion but do not reduce mortality; MRAs (spironolactone, eplerenone) are one of the four HFrEF pillars (see Heart Failure Drugs).
3.Adverse Effects
ClassKey adverse effects
LoopHypokalemia, hypomagnesemia, hyponatremia, hypocalcemia, hypochloremic metabolic alkalosis, dehydration and hypotension (orthostatic), prerenal AKI, ototoxicity (tinnitus, hearing loss — rapid IV, high doses, kidney failure, aminoglycosides), hyperuricemia and gout, hyperglycemia
ThiazideHypokalemia, hyponatremia (older women especially), hypomagnesemia, hypercalcemia, hyperuricemia and gout, hyperglycemia, raised lipids, photosensitivity, erectile dysfunction. Hydrochlorothiazide: small increased risk of nonmelanoma skin cancer (FDA label 2020) and rare acute angle-closure glaucoma (eye pain, sudden vision loss)
Potassium-sparingHyperkalemia (especially with CKD, diabetes, ACE inhibitors, ARBs, potassium supplements); spironolactone — gynecomastia, breast tenderness, menstrual irregularity, decreased libido; triamterene — kidney stones
MannitolFluid overload and pulmonary edema (initial volume expansion), electrolyte shifts, AKI at high osmolality, rebound intracranial pressure
AcetazolamideParesthesia, fatigue, metabolic acidosis, hypokalemia, kidney stones, altered taste of carbonated drinks

Boxed warning (furosemide, bumetanide): these potent diuretics can cause profound water and electrolyte depletion — dose and monitoring must be individualized.

4.Contraindications, Cautions & Interactions

Contraindications and cautions

  • Anuria (all diuretics); severe dehydration or hypovolemia; hepatic coma or precoma (risk of encephalopathy from hypokalemia and alkalosis)
  • Potassium-sparing: serum K⁺ above 5.0 mEq/L (mmol/L) at the start (MRAs in HF are not started if K⁺ ≥ 5.0 mEq/L or eGFR ≤ 30 mL/min/1.73 m²), severe kidney impairment, Addison disease; never with potassium supplements unless specifically ordered and monitored
  • Thiazides: gout, hyponatremia, hypercalcemia; less effective at eGFR below about 30 mL/min/1.73 m² (chlorthalidone is an exception in some studies)
  • Mannitol: anuria, severe HF or pulmonary edema, severe dehydration, active intracranial bleeding (except during craniotomy)
  • Sulfonamide allergy: loops (except ethacrynic acid), thiazides, and acetazolamide are sulfonamides; cross-reactivity with antibiotic sulfonamides is uncommon — ask about the reaction type and follow the prescriber's decision
  • Diabetes (thiazides and loops can raise glucose); older adults (falls, hyponatremia)

Pregnancy and lactation: diuretics are not used to treat edema of pregnancy or preeclampsia (they reduce plasma volume). Thiazides may be continued for chronic hypertension under specialist care. Spironolactone and other MRAs are avoided (antiandrogen effects on a male fetus; the 2025 hypertension guideline lists MRAs among drugs to avoid). High-dose diuretics can suppress lactation.

Major interactions

  • Digoxin + loop or thiazide: hypokalemia and hypomagnesemia → digoxin toxicity
  • Lithium: thiazides and loops raise lithium levels → toxicity
  • Aminoglycosides, cisplatin, vancomycin + loops: additive ototoxicity and nephrotoxicity
  • NSAIDs: blunt diuresis and BP lowering; NSAID + diuretic + ACE inhibitor/ARB ("triple whammy") → AKI
  • Potassium-sparing + ACE inhibitor, ARB, ARNI, potassium supplements, salt substitutes, trimethoprim → dangerous hyperkalemia
  • Corticosteroids, amphotericin B, stimulant laxatives, and beta-2 agonists add to hypokalemia
  • Other antihypertensives and alcohol add to orthostatic hypotension
  • Eplerenone and finerenone with strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir) → hyperkalemia; the combination is contraindicated
5.Monitoring & Nursing Interventions

Listed in priority order.

  1. Fluid status and perfusion
    • Daily weight — same time, same scale, same clothing, after voiding (best indicator of fluid change; 1 kg ≈ 1 L of fluid)
    • Strict intake and output; lung sounds, edema, JVD, dyspnea (response in HF)
    • BP including orthostatic readings; signs of dehydration (thirst, dry mucosa, poor skin turgor, dizziness, rising BUN)
    • Hold and notify for systolic BP < 90 mmHg or signs of hypovolemia, per order
  2. Electrolytes and kidney function (baseline, then regularly — more often with IV or high doses)
TestNormal rangeWatch for
Potassium3.5–5.0 mEq/L (mmol/L)Loop/thiazide: < 3.5 → notify before giving (per protocol). Potassium-sparing: > 5.0 → notify
Sodium135–145 mEq/L (mmol/L)Thiazides: hyponatremia (confusion, falls)
Magnesium1.7–2.2 mg/dL (0.70–0.91 mmol/L)Low Mg makes hypokalemia hard to correct and raises dysrhythmia risk
CreatinineAbout 0.6–1.2 mg/dL (53–106 µmol/L)Rising = volume depletion or kidney injury
Glucose, uric acid, calciumLaboratory referenceHyperglycemia, gout, hypercalcemia (thiazide)
Serum osmolality (mannitol)275–295 mOsm/kgCommonly hold if above about 320 mOsm/kg or per protocol
  1. Signs of electrolyte imbalance
    • Hypokalemia: muscle weakness, leg cramps, fatigue, constipation, flattened T waves, U waves, dysrhythmias
    • Hyperkalemia: weakness, paresthesia, peaked T waves, bradycardia, dysrhythmias
  2. Administration
    • Give once-daily diuretics in the morning (second dose, if ordered, by mid-afternoon) to avoid nocturia and falls
    • IV furosemide: slowly (about 4 mg/min or slower at high doses); assess hearing and tinnitus
    • IV potassium replacement: never IV push, always by pump; common peripheral maximum 10 mEq/h; confirm urine output
    • Mannitol: in-line filter; inspect for crystals; monitor urine output hourly, osmolality, and lung sounds
  3. Safety — fall precautions (urgency, orthostasis), especially in older adults at night; bedside commode or urinal
6.Client Education
  • Take the diuretic in the morning; plan outings around the peak effect
  • Weigh yourself every morning after voiding, before breakfast; report a gain of 2–3 lb (about 1 kg) in a day or 5 lb (about 2 kg) in a week, or a large loss with dizziness
  • Rise slowly; sit if dizzy; avoid hot baths and heavy alcohol use
  • Loop or thiazide: eat potassium-rich foods if allowed (bananas, oranges, potatoes, tomatoes, beans, leafy greens, dried fruit); take any prescribed potassium supplement with food and a full glass of water
  • Potassium-sparing (spironolactone, eplerenone, amiloride): avoid salt substitutes and potassium supplements unless prescribed; do not overload on high-potassium foods
  • Report muscle weakness, cramps, palpitations, ringing in the ears, severe thirst, or very low urine output
  • Thiazides: use sunscreen and check the skin regularly; report joint pain (gout) or sudden eye pain
  • Sick-day advice: during vomiting, diarrhea, or poor fluid intake, contact the prescriber — the diuretic may need to be held temporarily
  • Avoid NSAIDs (ibuprofen, naproxen) unless the prescriber approves
  • Diabetes: check glucose more often after starting a thiazide or loop diuretic
7.Toxicity, Overdose & Antidotes

There is no specific antidote for diuretics. Overdose or overuse causes:

ProblemFindingsAction
Volume depletionHypotension, tachycardia, dizziness, syncope, rising BUN and creatinine, low urine outputHold diuretic, notify, IV isotonic fluids as ordered
Severe hypokalemiaWeakness, ileus, U waves, ventricular dysrhythmias, digoxin toxicityCardiac monitoring; potassium (and magnesium) replacement per protocol
Severe hyponatremiaConfusion, seizuresEmergency care; correct slowly to avoid osmotic demyelination
Hyperkalemia (potassium-sparing)Peaked T waves, wide QRS, bradycardia, arrest (emergency at K⁺ ≥ 6.5 mEq/L or any level with ECG changes)Stop the drug; IV calcium (stabilizes the heart), insulin with dextrose and inhaled albuterol (shift K⁺ into cells), potassium binders, loop diuretic if kidneys work, dialysis
OtotoxicityTinnitus, hearing loss, vertigoStop or slow infusion, notify; may be permanent
Mannitol overloadPulmonary edema, rising osmolalityStop, notify; loop diuretic or dialysis per order
8.High-Yield Points
  • Loop (furosemide) = most potent; thiazides = first-line for hypertension; potassium-sparing = weak, raise K⁺
  • Loop and thiazide → ↓K⁺, ↓Mg²⁺, ↓Na⁺, metabolic alkalosis, ↑uric acid, ↑glucose
  • Loop ↓calcium; thiazide ↑calcium
  • Normal K⁺ 3.5–5.0 mEq/L (mmol/L); hypokalemia + digoxin = toxicity
  • Furosemide: ototoxicity — give high IV doses slowly (about 4 mg/min)
  • Spironolactone: hyperkalemia, gynecomastia; no salt substitutes
  • Daily weight is the best measure of response; give in the morning
  • Diuretics raise lithium levels; NSAIDs blunt diuretics
  • Mannitol: raised ICP; monitor osmolality; contraindicated in anuria and pulmonary edema
  • Acetazolamide → metabolic acidosis; loops and thiazides → metabolic alkalosis

Country Notes

United States

  • Weight thresholds are usually taught in pounds; many HF programs give a written plan for extra diuretic doses based on weight.
  • Salt substitutes sold in grocery stores (potassium chloride) are a hidden source of potassium — ask about them specifically.

Philippines

  • Laboratories commonly report creatinine in µmol/L and may report electrolytes in mmol/L; check units against teaching thresholds.
  • Coconut water (buko juice) is rich in potassium; it can help clients on loop or thiazide diuretics but is a hyperkalemia risk for those on spironolactone, ACE inhibitors, or ARBs and for clients with kidney disease.
  • In hot weather, heavy sweating plus a diuretic increases the risk of dehydration and hyponatremia; adjust fluid teaching accordingly.

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.